How does metformin lower blood glucose
Pro Research Analysisby 
Searched over 200M research papers
How Metformin Lowers Blood Glucose: Mechanisms and Insights
Metformin is a widely prescribed medication for managing type 2 diabetes mellitus (T2DM). Despite its extensive use, the precise mechanisms by which it lowers blood glucose levels are multifaceted and not entirely understood. This article synthesizes current research to elucidate how metformin achieves its glucose-lowering effects.
Reduction of Hepatic Glucose Production
One of the primary mechanisms by which metformin lowers blood glucose is through the reduction of hepatic glucose production (HGP). Metformin inhibits gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate sources. This inhibition is partly mediated by the activation of AMP-activated protein kinase (AMPK) in the liver, which decreases the expression of genes involved in gluconeogenesis Cusi1996Sanchez-Rangel2017Duca2015. Additionally, metformin's inhibition of the mitochondrial respiratory chain complex 1 alters cellular energy charge and redox state, further suppressing gluconeogenesis .
Enhancement of Peripheral Glucose Utilization
Metformin also enhances peripheral glucose utilization, particularly in muscle tissues. This effect is achieved through increased insulin sensitivity, which facilitates glucose uptake by cells Cusi1996Yoshida2009. Although metformin does not significantly improve oxidative or non-oxidative glucose disposal during insulin stimulation, it does increase glucose uptake and subsequent lactate production in muscle cells Cusi1996Yoshida2009.
Gut-Based Mechanisms and GLP-1 Secretion
Recent studies have highlighted the role of the gastrointestinal tract in metformin's glucose-lowering action. Metformin increases the secretion of glucagon-like peptide-1 (GLP-1), an incretin hormone that enhances insulin secretion and inhibits glucagon release, thereby lowering blood glucose levels DeFronzo2016Bahne2018Sansome2019+1 MORE. This effect is mediated through a direct action on GLP-1-secreting L cells in the gut, which is dependent on AMPK activity . Additionally, metformin's ability to reduce intestinal bile acid resorption contributes to increased GLP-1 secretion and improved glycemic control Sansome2019Foretz2019.
Modulation of Gut Microbiota
Emerging evidence suggests that metformin may also exert its effects by modulating the gut microbiota. Changes in the composition of gut bacteria can influence glucose metabolism and insulin sensitivity, providing another layer of complexity to metformin's action .
Conclusion
Metformin lowers blood glucose through a combination of mechanisms, including the reduction of hepatic glucose production, enhancement of peripheral glucose utilization, and modulation of gut-based processes such as GLP-1 secretion and bile acid metabolism. These multifaceted actions make metformin a highly effective and versatile treatment for type 2 diabetes, although further research is needed to fully understand its complex mechanisms.
Sources and full results
Most relevant research papers on this topic